Skip to Main Content
Legislation Search

H.R. 500: Medicare Hearing Aid Coverage Act of 2025

This bill, known as the Medicare Hearing Aid Coverage Act of 2025, aims to amend the Social Security Act to expand Medicare coverage regarding hearing aids and the associated examinations. Here are the main points of the bill:

Removal of Coverage Exclusion

The bill intends to eliminate the existing exclusion within Medicare that currently prevents coverage for hearing aids and the examinations required to obtain them. Specifically, it would amend Section 1862(a)(7) of the Social Security Act by removing the phrase that explicitly excludes "hearing aids or examinations therefor." This change would allow Medicare to cover these services beginning January 1, 2026.

Study on Hearing Aid Programs

In addition to the coverage changes, the bill mandates that the Comptroller General of the United States conduct a comprehensive study on programs that provide assistance for hearing aids and related examinations. The study will focus on:

  • Identifying the number of individuals in the United States who require hearing aids and their current coverage under federal and private programs.
  • Evaluating the effectiveness of these programs in meeting the needs of individuals with hearing loss.
  • Investigating existing programs aimed at reducing or mitigating hearing loss.

The findings from this study will be reported to Congress within 18 months of the effective date of the coverage change. The report may also include recommendations for new programs or modifications to existing ones to better serve individuals with hearing loss.

Implementation Timeline

The changes brought about by this legislation will take effect on January 1, 2026. After this date, individuals eligible for Medicare will have access to coverage for hearing aids and the necessary evaluations.

Potential Implications

This legislation would potentially impact the way hearing aids are accessed and financed for Medicare beneficiaries, aiming to improve both availability and affordability of these essential devices and services.

Relevant Companies

  • DEO - Companies that produce hearing aids may see a direct impact from an increased demand for their products as more individuals gain access to coverage under Medicare.
  • HSIC - Health sciences companies involved in diagnostic equipment and audiology may experience changes in service utilization related to Medicare coverage.

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

25 bill sponsors

Actions

2 actions

Date Action
Jan. 16, 2025 Introduced in House
Jan. 16, 2025 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Corporate Lobbying

0 companies lobbying

None found.

* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.

Potentially Relevant Congressional Stock Trades

Estimated excess return of the underlying stock since the transaction
Politician Stock Transaction Filed Traded
Congress pfp
Ro Khanna D / House
HSIC logo
HSIC HENRY SCHEIN INC COMMON STOCK
Sale $1,001 - $15,000
May 12, 2025 Apr 15, 2025 -5.85%
Congress pfp
Robert Bresnahan R / House
HSIC logo
HSIC HENRY SCHEIN, INC. - COMMON STOCK
Purchase $1,001 - $15,000
May 08, 2025 Apr 08, 2025 -12.54%
Congress pfp
Julie Johnson D / House
HSIC logo
HSIC HENRY SCHEIN, INC. - COMMON STOCK
Sale $1,001 - $15,000
May 14, 2025 Apr 01, 2025 -8.60%
Congress pfp
Gilbert Ray Cisneros, Jr. D / House
HSIC logo
HSIC HENRY SCHEIN, INC. - COMMON STOCK
Sale $1,001 - $15,000
Apr 07, 2025 Mar 31, 2025 -8.14%
Congress pfp
George Whitesides D / House
DEO logo
DEO STOCK, COMPANY-SPECIFIC HOLDINGS INTO PASSIVE ETFS AND MUTUAL FUNDS, PER BEST PRACTICES. C�������: TO AVOID ANY POSSIBLE CONFLICTS OF INTEREST WITH MY FUTURE CONGRESSIONAL WORK, I’M TRANSITIONING MY SINGLE STOCK, COMPANY-SPECIFIC HOLDINGS INTO PASSIVE ETFS AND MUTUAL FUNDS, PER BEST PRACTICES. DIAGEO PLC COMMON STOCK
Sale $15,001 - $50,000
Apr 23, 2025 Mar 24, 2025 -12.37%
Congress pfp
Kelly Morrison D / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Sale $1,001 - $15,000
Apr 11, 2025 Mar 20, 2025 -15.90%
Congress pfp
Kelly Morrison D / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Sale $1,001 - $15,000
Apr 11, 2025 Mar 20, 2025 -15.90%
Congress pfp
Kelly Morrison D / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Sale $1,001 - $15,000
Apr 11, 2025 Mar 20, 2025 -15.90%
Congress pfp
Josh Gottheimer D / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Sale $1,001 - $15,000
Apr 10, 2025 Mar 19, 2025 -14.27%
Congress pfp
Ro Khanna D / House
HSIC logo
HSIC HENRY SCHEIN INC COMMON STOCK
Sale $1,001 - $15,000
Apr 10, 2025 Mar 06, 2025 -11.76%
Congress pfp
Ro Khanna D / House
HSIC logo
HSIC HENRY SCHEIN INC COMMON STOCK
Purchase $1,001 - $15,000
Feb 06, 2025 Jan 17, 2025 -7.60%
Congress pfp
Tommy Tuberville R / Senate
DEO logo
DEO Diageo Plc ADR
Sale (Full) $15,001 - $50,000
Feb 14, 2025 Jan 10, 2025 -21.20%
Congress pfp
Ro Khanna D / House
HSIC logo
HSIC HENRY SCHEIN INC COMMON STOCK
Purchase $1,001 - $15,000
Dec 05, 2024 Nov 15, 2024 -3.46%
Congress pfp
John James R / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Sale $1,001 - $15,000
Sep 06, 2024 Sep 04, 2024 -34.46%
Congress pfp
Michael T. McCaul R / House
HSIC logo
HSIC HENRY SCHEIN, INC.
Sale $1,001 - $15,000
Sep 16, 2024 Aug 26, 2024 -11.32%
Congress pfp
Michael T. McCaul R / House
HSIC logo
HSIC HENRY SCHEIN, INC.
Sale $1,001 - $15,000
Sep 16, 2024 Aug 26, 2024 -11.32%
Congress pfp
Ro Khanna D / House
DEO logo
DEO DIAGEO ADR
Sale $1,001 - $15,000
Jul 08, 2024 Jun 26, 2024 -34.79%
Congress pfp
Ro Khanna D / House
DEO logo
DEO DIAGEO ADR
Sale $1,001 - $15,000
Jul 08, 2024 Jun 26, 2024 -34.79%
Congress pfp
Ro Khanna D / House
DEO logo
DEO DC DIAGEO ADR
Sale $1,001 - $15,000
Jul 08, 2024 Jun 26, 2024 -34.79%
Congress pfp
Josh Gottheimer D / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Sale $1,001 - $15,000
Jul 09, 2024 Jun 18, 2024 -34.90%
Congress pfp
Ro Khanna D / House
HSIC logo
HSIC HENRY SCHEIN INC COMMON STOCK
Sale $1,001 - $15,000
Jun 05, 2024 May 29, 2024 -17.52%
Congress pfp
Sheldon Whitehouse D / Senate
DEO logo
DEO Diageo Plc ADR
Sale (Full) $15,001 - $50,000
Jun 06, 2024 May 08, 2024 -48.20%
Congress pfp
John James R / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Purchase $1,001 - $15,000
Sep 02, 2024 Mar 05, 2024 -54.53%
Congress pfp
Michael T. McCaul R / House
HSIC logo
HSIC HENRY SCHEIN, INC.
Sale $1,001 - $15,000
Feb 13, 2024 Jan 17, 2024 -34.42%
Congress pfp
Michael T. McCaul R / House
HSIC logo
HSIC HENRY SCHEIN, INC.
Sale $1,001 - $15,000
Feb 13, 2024 Jan 17, 2024 -34.42%
Congress pfp
Earl Blumenauer D / House
DEO logo
DEO DIAGEO PLC
Purchase $15,001 - $50,000
Jan 04, 2024 Dec 07, 2023 -63.52%
Congress pfp
Ro Khanna D / House
HSIC logo
HSIC HENRY SCHEIN INC COMMON STOCK
Purchase $1,001 - $15,000
Jan 04, 2024 Dec 04, 2023 -34.32%
Congress pfp
Lois Frankel D / House
DEO logo
DEO DIAGEO PLC
Sale $1,001 - $15,000
Oct 10, 2023 Sep 08, 2023 -76.74%
Congress pfp
Ro Khanna D / House
HSIC logo
HSIC HENRY SCHEIN INC COMMON STOCK
Sale $1,001 - $15,000
Sep 06, 2023 Aug 03, 2023 -48.46%